AKT1 and hepatocellular carcinoma: According to research, LncRNA-PDPK2P promotes hepatocellular carcinoma (HCC) progression via the PDK1/Akt/Casepase-3 signaling pathway, and PDPK2P expression can be used as a prognostic marker for HCC (18).